We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$506M
AUM Growth
+$32.5M
Cap. Flow
-$11.6M
Cap. Flow %
-2.3%
Top 10 Hldgs %
47.1%
Holding
174
New
17
Increased
13
Reduced
54
Closed
6

Top Buys

Rank Stock Value
1
AVY icon
Avery Dennison
AVY
+$449K
2
CVS icon
CVS Health
CVS
+$248K
3
MMM icon
3M
MMM
+$223K
4
MSFT icon
Microsoft
MSFT
+$181K
5
HON icon
Honeywell
HON
+$111K

Top Sells

Rank Stock Value
1
HXL icon
Hexcel
HXL
+$1.46M
2
AMD icon
Advanced Micro Devices
AMD
+$759K
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$746K
4
DHR icon
Danaher
DHR
+$396K
5
HD icon
Home Depot
HD
+$386K

Sector Composition

Rank Sector Weight
1 Technology 29.14%
2 Healthcare 16.36%
3 Financials 16.31%
4 Communication Services 9.6%
5 Consumer Staples 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$417B
$7.09M 1.4%
45,062
-1,333
-3% -$193K
CSCO icon
27
Cisco
CSCO
$475B
$6.93M 1.37%
109,373
-1,212
-1% -$69.2K
PG icon
28
Procter & Gamble
PG
$338B
$4.53M 0.89%
27,660
-500
-2% -$74.2K
AFL icon
29
Aflac
AFL
$60.7B
$3.84M 0.76%
65,825
-156
-0.2% -$8.74K
HXL icon
30
Hexcel
HXL
$7.6B
$3.42M 0.68%
66,120
-25,700
-28% -$1.46M
EW icon
31
Edwards Lifesciences
EW
$54B
$3.38M 0.67%
26,075
CRM icon
32
Salesforce
CRM
$162B
$3.34M 0.66%
13,135
-70
-0.5% -$19.7K
WWD icon
33
Woodward
WWD
$21.1B
$3.22M 0.64%
29,440
MSFT icon
34
Microsoft
MSFT
$3.74T
$3.06M 0.61%
9,110
+557
+7% +$181K
CVX icon
35
Chevron
CVX
$386B
$3.05M 0.6%
25,989
-58
-0.2% -$6.59K
JPM icon
36
JPMorgan Chase
JPM
$962B
$1.99M 0.39%
12,562
-983
-7% -$161K
ABBV icon
37
AbbVie
ABBV
$442B
$1.87M 0.37%
13,803
-742
-5% -$87.6K
WFC.PRL icon
38
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.69M 0.33%
1,134
-41
-3% -$61.2K
VRSN icon
39
VeriSign
VRSN
$26B
$1.51M 0.3%
5,962
SCHW
40
Charles Schwab
SCHW
$186B
$1.45M 0.29%
17,293
RITM.PRB icon
41
Rithm Capital Corp 7.125% Series B Preferred Stock
RITM.PRB
$284M
$1.34M 0.27%
52,933
-4,167
-7% -$105K
PFE icon
42
Pfizer
PFE
$152B
$1.3M 0.26%
22,048
+790
+4% +$39.1K
RDS.A
43
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.12M 0.22%
25,724
-1,800
-7% -$81.3K
GILD icon
44
Gilead Sciences
GILD
$168B
$1.1M 0.22%
15,205
-700
-4% -$48.2K
AVY icon
45
Avery Dennison
AVY
$13.6B
$1.06M 0.21%
4,900
+2,100
+75% +$449K
VZ icon
46
Verizon
VZ
$196B
$1.04M 0.21%
20,035
DOW icon
47
Dow Inc
DOW
$22.6B
$998K 0.2%
17,594
-511
-3% -$29.1K
UNM icon
48
Unum
UNM
$14.2B
$906K 0.18%
36,875
-5,300
-13% -$136K
ABT icon
49
Abbott
ABT
$190B
$853K 0.17%
6,060
AMGN icon
50
Amgen
AMGN
$224B
$668K 0.13%
2,970
-300
-9% -$63.3K

Similar funds

Kelly Lawrence W & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Kelly Lawrence W & Associates held 174 positions worth $506M, up 6.9% from $473M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Kelly Lawrence W & Associates's Q4 2021 filing shows 17 new, 13 increased, 54 reduced and 6 closed positions. Its largest new stake was CVS Health: 2,685 shares worth $277K. The largest sale was Hexcel, an estimated $1.46M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Kelly Lawrence W & Associates's largest Q4 2021 buy was CVS Health: 2,685 shares worth $277K.
  • Kelly Lawrence W & Associates added most to Avery Dennison in Q4 2021, an estimated $449K increase.
  • Kelly Lawrence W & Associates's biggest Q4 2021 reduction was Hexcel, cutting an estimated $1.46M.
  • Kelly Lawrence W & Associates fully exited iShares Core S&P Mid-Cap ETF in Q4 2021, selling an estimated $158K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 47% of its $506M portfolio in Q4 2021.
  • Kelly Lawrence W & Associates opened 17 new positions and closed 6 in Q4 2021.
  • Kelly Lawrence W & Associates's portfolio value rose 6.9% quarter-over-quarter to $506M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2021, filed 11 Feb 2022.